Retatrutide, developed by Soma Pharmaceuticals , represents a exciting breakthrough in metabolic regulation. This unique medication combines GLP-1 signaling function with GIP pathway stimulation , showing substantial efficacy in trial findings for weight reduction . Experts believe Retatrutide may provide a alternative pathway for people experienci